US FDA issued warning against manufacturers of mousse or whipped cream sunscreen products Dr. Kamal Kant Kohli23 Aug 2025 9:45 AM ISTThe FDA has issued warnings to multiple manufacturers of mousse or whipped cream sunscreen products, citing concerns highlighted on the agency's...
Scientists Grow World's First Fully Functional Human Skin with Blood Supply Dr. Bhumika Maikhuri23 Aug 2025 8:30 AM ISTIn a recent study, researchers at the University of Queensland (UQ) have developed the world's first fully functional lab-grown human skin complete...
Low-Dose Oral Minoxidil for Hair Loss Not Linked to Tachycardia, Large Study Suggests Medha Baranwal22 Aug 2025 9:00 PM ISTUSA: A new retrospective study published in the Journal of the American Academy of Dermatology (JAAD) reports that low-dose oral minoxidil (LDOM),...
Atopic Dermatitis Linked to 27 Percent Higher Stroke Risk, Meta-Analysis Finds Medha Baranwal22 Aug 2025 8:45 PM ISTChina: A new meta-analysis published in Frontiers in Neurology has revealed a significant association between atopic dermatitis (AD) and an increased...
Poor Heart-Kidney-Metabolic Health and Genetics May Double Psoriasis Risk, Study Finds Medha Baranwal21 Aug 2025 9:15 PM ISTChina: A new large-scale study has found that declining cardiovascular-kidney-metabolic (CKM) health, combined with genetic susceptibility, is...
Lebrikizumab Shows Strong Efficacy and Safety in Atopic Dermatitis: Study Dr. Shravani Dali20 Aug 2025 8:45 PM ISTAtopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that significantly impacts quality of life and often requires systemic...
Dupilumab in Atopic Dermatitis Linked to Significant Weight Gain, Study Finds Medha Baranwal19 Aug 2025 9:30 PM ISTIreland: A new study from researchers at Tallaght University Hospital, Dublin, highlights a potential link between dupilumab therapy and weight gain...
Tildrakizumab Shows Significant Efficacy in Psoriatic Arthritis Phase 3 Trials Dr. Kamal Kant Kohli18 Aug 2025 8:30 PM ISTPhase 3 trials have demonstrated that tildrakizumab 100mg significantly improved ACR20 response rates in patients with active psoriatic arthritis at...
Type II cryoglobulinemic vasculitis associated with poor prognosis in patients with Sjogren disease: JAMA Jacinthlyn Sylvia17 Aug 2025 8:15 PM ISTA new study published in the Journal of American Medical Association showed that Type II cryoglobulinemic vasculitis was the most common form of...
Real-World Study Confirms Baricitinib's Effectiveness for Alopecia Areata Dr. Shravani Dali15 Aug 2025 9:30 PM ISTA recent real-world study conducted in China has confirmed that baricitinib, a Janus kinase (JAK) inhibitor, significantly improves hair regrowth in...
Gene-based blood test for melanoma may predict recurrence, reveals research Dr. Kamal Kant Kohli13 Aug 2025 8:00 PM ISTMonitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows. Led by...
Rilzabrutinib reduces itch and hives in patients with chronic spontaneous urticaria: JAMA Jacinthlyn Sylvia13 Aug 2025 6:00 AM ISTA new study published in the Journal of American Medical Association found that Rilzabrutinib decreased itching and hives while preserving a positive...
